Myeongmun Pharmaceutical, Active Community... Stock Price Up 26.21%.
At this time, posts about Myeongmun Pharmaceutical are rapidly increasing on portals and stock communities. Today, foreigners have sold a net 20,000 shares of Myeongmun Pharmaceutical, while institutions have bought a net 2,000 shares, according to provisional data. Myeongmun Pharmaceutical is known as a comprehensive pharmaceutical company specializing in prescription drugs.
As of 12:31 PM on the 21st, Myeongmun Pharmaceutical's stock price is 9,150 KRW, up 26.21% from the previous day, with a trading volume of 36,937,231 shares, which is 926.88% of the 5-day average trading volume. On December 18th, Myeongmun Pharmaceutical became an issue in the market by announcing the release of 'Hoistar Tablets,' an oral COVID-19 treatment with the same active ingredient...
In addition to Myeongmun Pharmaceutical, posts by investors are also surging for Sinsung ENG (011930), Ssangyong Motor (003620), and Otek (067170).
Hot Picks Today
"Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- [Breaking] Samsung Labor-Management 'Performance Bonus Negotiations' Fail in Third Mediation... Union Says "General Strike to Proceed as Planned Tomorrow"
- [Breaking] Blue House: "Deeply Regret Central Labor Relations Commission Post-Mediation Breakdown... Urge Labor and Management to Do Their Best Until the End"
- "Don't Throw Away Coffee Grounds" Transformed into 'High-Grade Fuel' in Just 90 Seconds [Reading Science]
- "Even With a 90 Million Won Salary and Bonuses, It Doesn’t Feel Like Much"... A Latecomer Rookie Who Beat 70 to 1 Odds [Scientists Are Disappearing] ③
※Source: AI Investment Assistant AI Lassiro
※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
